CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
Pinpoint Appother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03291613
NCT03291613N/ACompleted
CompareCT.gov

PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Management

Klein Buendel, Inc.·interventional·Posted Sep 25, 2017·Updated Feb 6, 2019

In Brief

A clinical study evaluating Pinpoint App for Sickle Cell Disease. Completed, enrolled 13 participants across 2 sites.

Detailed Summary

Sickle cell disease (SCD) is a common genetic disorder characterized by episodes of pain, yet assessments to identify type, intensity, frequency, and phase of pain among SCD adolescents is lacking. Research shows that interactive gaming technology can enhance adolescents' learning, and can be especially effective in delivering health-related messages and tools to improve their self-care. Pinpoint is an interactive gaming tablet app that will be developed with the significant input of clinical experts to assist SCD teens with better identification and self-report of their pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSickle Cell Disease
CountriesUnited States
CollaboratorsHPC International, Inc., National Institute on Minority Health and Health Disparities (NIMHD)

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 25, 2017
Enrollment StartJan 15, 2017
Primary CompletionSep 30, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 8.8 years ago

Interventions

Pinpoint Appother

Tablet app with pain assessment and communication education, and pain assessment tool.